Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Santen files NDA for levofloxacin 1.5%

May 9, 2003

INS-37217 reported effective as adjunct in retinal reattachment surgery

May 9, 2003

Improved retinal thickness found with midostaurin in diabetic macular edema

May 8, 2003

Dry eye symptoms improve after transdermal application of testosterone cream

May 8, 2003

Cell adhesion inhibitor K-7174 exerts beneficial effects in murine model of Sjogren's syndrome

May 7, 2003

Roscovitine inhibits the proliferation of RPE cells

May 7, 2003

Porphyrin-based photosensitizers for use in ocular disorders, cancer, etc.

May 7, 2003

Approval and/or launch of major ophthalmic products reported by Allergan

May 5, 2003

Allergan and Acadia announce new drug discovery and development collaboration

May 5, 2003

ISV-403 moves into phase I clinical trials

May 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.